Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Glioblastoma Educational Needs Survey


Published on

The purpose of this survey was to identify perceived educational needs regarding the management of older patients with glioblastoma multiforme (GBM)

Published in: Education
  • Be the first to comment

  • Be the first to like this

Glioblastoma Educational Needs Survey

  1. 1. Glioblastoma Educational Needs Survey The purpose of this survey was to identify perceived educational needs regarding the management of older patients with glioblastoma multiforme (GBM)
  2. 2. Demographics Total Respondents N = 25
  3. 3. Demographics How many patients with GBM do you manage per week? What percentage of your patients with GBM are 70 years of age or older? 0 to 3 >4 0 25% to 100% Percent of Respondents
  4. 4. Rate the extent to which you agree with each of the following statements: Treatment of patients with recurrent GBM is often a challenge The performance status of my older patients plays a critical role in guiding treatment decisions I know the contraindications to administration of bevacizumab in patients with GBM Mean Response (Strongly disagree, 1; Strongly agree, 5) N = 25
  5. 5. How frequently do you: Encourage clinical trial participation for your older GBM patients? Use an aggressive multimodal treatment approach (ie, surgery, radiation, chemotherapy) in a 74-year-old patient with GBM? Assess MGMT methylation in your older patients with GBM? Mean Response (Never, 1; Always, 5) Use concurrent and adjuvant TMZ with RT in your older patients with moderate medical comorbidities and who require assistance in some activities of daily living? N = 25
  6. 6. How would you manage a 78-year-old GBM patient with arthritis, adequately controlled diabetes, and whose GBM improved following aggressive surgical resection of the tumor? Short-course of radiation therapy (ie, 2-3 weeks) only None, palliative care Temozolomide only Percent of Respondents Short-course of radiation therapy (ie, 2-3 weeks) + temozolomide Concurrent and adjuvant temozolomide with radiation therapy (ie, Stupp regimen) N = 25
  7. 7. Please rate your confidence in each of the following: Differentiation radiographic changes that mimic tumor progression from legitimate radiographic changes in tumor size following treatment Communicating with my older patients about the value of clinical trial participation Identifying clinical trials to enroll my older patients Mean Response (Not at all confident, 1; Extremely confident, 5) Managing older patients Assessing performance status/patient fitness Managing treatment-related side effects Communicating with neurologists, oncologists, radiation oncologists, and neurogsurgeons N = 25
  8. 8. Please list practice areas in which you would like more information <ul><li>More ground-breaking news on GBM </li></ul><ul><li>Side effects </li></ul><ul><li>Use of temozolomide, other chemotherapeutic agents and medications for paliative care </li></ul><ul><li>Prognostic factors </li></ul><ul><li>New drugs </li></ul><ul><li>Case stories of difficulty </li></ul><ul><li>New treatment strategies </li></ul><ul><li>Surgical procedures, post-op management, radiation side effects, medication course for mild to severe disease process </li></ul><ul><li>Treatment progression options for further care </li></ul><ul><li>Information on bevacizumab in the treatment of GBM as well as matters related to MGMT meth </li></ul><ul><li>More online support groups </li></ul><ul><li>Toxicity management </li></ul><ul><li>Treatment protocols for older patients </li></ul><ul><li>ASSESSMENT OF POST HOPSITAL CARE IN PATIENTS LIVING ON FIXED INCOME </li></ul>